ICUI vs. WST, ALGN, MMSI, XRAY, HAE, QDEL, NEOG, STAA, CERS, and OSUR
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), and OraSure Technologies (OSUR). These companies are all part of the "health care supplies" industry.
ICU Medical vs.
West Pharmaceutical Services (NYSE:WST) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking.
West Pharmaceutical Services has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500.
ICU Medical received 123 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 64.37% of users gave ICU Medical an outperform vote while only 56.04% of users gave West Pharmaceutical Services an outperform vote.
West Pharmaceutical Services has higher revenue and earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
West Pharmaceutical Services presently has a consensus price target of $344.00, indicating a potential upside of 63.25%. ICU Medical has a consensus price target of $199.67, indicating a potential upside of 26.84%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, equities analysts clearly believe West Pharmaceutical Services is more favorable than ICU Medical.
West Pharmaceutical Services has a net margin of 17.03% compared to ICU Medical's net margin of -4.74%. West Pharmaceutical Services' return on equity of 18.60% beat ICU Medical's return on equity.
In the previous week, West Pharmaceutical Services had 15 more articles in the media than ICU Medical. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 4 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.61 beat West Pharmaceutical Services' score of 0.36 indicating that ICU Medical is being referred to more favorably in the news media.
93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 6.7% of ICU Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
West Pharmaceutical Services beats ICU Medical on 13 of the 18 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ICU Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICUI) was last updated on 2/22/2025 by MarketBeat.com Staff
Free ICUI Stock Alerts